Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
20 hedge funds and large institutions have $47.1M invested in Minerva Surgical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more funds holding
Funds holding: 20 → 20 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
44% less capital invested
Capital invested by funds: $84.7M → $47.1M (-$37.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$702K |
| 2 |
LM
Luminus Management
Houston,
Texas
|
+$399K |
| 3 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
+$379K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$369K |
| 5 |
FRA
Frank Rimerman Advisors
Palo Alto,
California
|
+$322K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$874K |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$375K |
| 3 |
CCM
CAAS Capital Management
New York
|
-$334K |
| 4 |
PA
Perceptive Advisors
New York
|
-$226K |
| 5 |
Two Sigma Advisers
New York
|
-$59K |
UTRS Hedge Fund Activity: Q2 2022 in Review
20 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q2 2022, worth a combined $47.1M — down 44% from $84.7M a quarter earlier.
Fund positioning in UTRS was balanced in Q2 2022: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $702K. The largest seller was Fidelity Investments, cutting an estimated $874K.
- 20 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $47.1M of Minerva Surgical, Inc. Common Stock stock for Q2 2022, down 44% quarter-over-quarter.
- 5 funds opened new Minerva Surgical, Inc. Common Stock positions in Q2 2022 and 5 closed out, a net change of 0 holders.
- The largest Minerva Surgical, Inc. Common Stock buyer in Q2 2022 was AWM Investment Company, an estimated $702K added.
- The largest Minerva Surgical, Inc. Common Stock seller in Q2 2022 was Fidelity Investments, an estimated $874K sold.
Based on aggregated 13F filings for Q2 2022.